TIGIT+ Treg-infiltrating tumors have been found to be characterized by an upregulation of TIM-3, and inhibiting TIM-3 in Tigit−/− mice further reduces tumor size and increases overall survival [67]. This evidence concerns the gene HAVCR2 and neoplasm.